FEops HEARTguide vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose FEops HEARTguide if…
Choose FEops HEARTguide if you require advanced pre-operative planning and predictive simulations for complex structural heart interventions. This platform is ideal for cardiologists and cardiothoracic surgeons who need to optimize device sizing and positioning using patient-specific digital twins and AI-based anatomical measurements to improve procedural outcomes.
View FEops HEARTguide →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is the early, non-invasive detection of low ejection fraction during routine physical exams. This tool is best suited for clinicians in primary care or general cardiology seeking to quickly screen patients for heart failure risk using an AI algorithm integrated with a digital stethoscope.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FEops HEARTguide | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Cloud Based platform | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) is designed for rapid, non-invasive screening during routine physical exams, integrating with a familiar tool like a stethoscope and providing quick results in approximately 15 seconds.. This makes it highly accessible and easy to incorporate into a primary care workflow for early detection.
Clinical Value
FEops HEARTguideFEops HEARTguide has demonstrated a direct and significant impact on improving procedural efficiency and clinical outcomes in complex structural heart interventions through randomized controlled trials and real-world evidence.. It leads to tangible reductions in complications, such as a 20% reduction in procedural time and 100% procedural success without major complications in LAAO procedures, and improved success rates in TAVI planning.
Pricing & Value
Eko Low Ejection Fraction Tool (ELEFT)Both tools require direct contact for pricing, limiting transparency. However, ELEFT explicitly highlights its ability to detect low ejection fraction at a 'fraction of the time and cost of echocardiography,' suggesting a clear value proposition for cost-effective early screening of a widespread condition.. While FEops HEARTguide also claims cost reduction through efficiency, ELEFT's direct comparison to a more expensive diagnostic method offers a more explicit and potentially broader value proposition.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)ELEFT is explicitly marketed as part of Eko's SENSORAu2122 'enterprise solution' and platform, designed for health systems and integrated delivery networks, and explicitly mentions having a Business Associate Agreement (BAA).. While FEops HEARTguide is cloud-based, HIPAA compliant, and FDA cleared, ELEFT's explicit focus on an enterprise platform and BAA demonstrates a more direct and comprehensive approach to enterprise readiness.
Innovation
FEops HEARTguideFEops HEARTguide leverages advanced digital twin technology combined with AI to create patient-specific replicas and predictive simulations, offering a deeper level of personalized procedural planning and outcome forecasting.. This digital twin approach, which simulates complex device-anatomy interactions, represents a more fundamentally innovative and complex technological advancement compared to ELEFT's AI-powered diagnostic screening at the point of care.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health offers a well-structured and accessible support ecosystem, including a dedicated Help Center with user manuals (available in multiple languages), FAQs, and multiple direct contact options like email and scheduled phone calls with a Customer Experience team.. In contrast, specific details regarding comprehensive customer support and documentation for FEops HEARTguide were not readily available in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FEops HEARTguide | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | FEops HEARTguide | Eko Low Ejection Fraction Tool (ELEFT) |
| Primary Purpose | Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Company | FEops NV | Eko Health |
| Key Technology/Methodology | Predictive simulation technology, AI-based anatomical measurements, Digital twin technology for patient-specific replicas. | AI-powered low ejection fraction detection, analyzes ECG and heart sound recordings. |
| Integration/Hardware Requirement | DICOM interface for CT scan upload. | Integrates with FDA-cleared Eko digital stethoscopes. |
| Target Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring FEops HEARTguide and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring FEops HEARTguide or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.